Agilent Technologies, Inc. $A Shares Sold by Impax Asset Management Group plc

Impax Asset Management Group plc lessened its holdings in Agilent Technologies, Inc. (NYSE:A) by 2.0% during the third quarter, Holdings Channel.com reports. The firm owned 2,961,796 shares of the medical research company’s stock after selling 61,046 shares during the quarter. Agilent Technologies makes up 2.2% of Impax Asset Management Group plc’s investment portfolio, making the stock its 9th largest position. Impax Asset Management Group plc’s holdings in Agilent Technologies were worth $380,147,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Vanguard Group Inc. grew its holdings in Agilent Technologies by 1.8% during the second quarter. Vanguard Group Inc. now owns 33,997,845 shares of the medical research company’s stock worth $4,012,086,000 after acquiring an additional 589,219 shares during the period. Massachusetts Financial Services Co. MA grew its stake in shares of Agilent Technologies by 10.7% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 13,227,387 shares of the medical research company’s stock worth $1,560,964,000 after purchasing an additional 1,273,994 shares during the period. Geode Capital Management LLC grew its stake in shares of Agilent Technologies by 1.6% during the 2nd quarter. Geode Capital Management LLC now owns 7,319,530 shares of the medical research company’s stock worth $860,137,000 after purchasing an additional 115,183 shares during the period. Generation Investment Management LLP increased its holdings in shares of Agilent Technologies by 15.9% in the 2nd quarter. Generation Investment Management LLP now owns 5,775,860 shares of the medical research company’s stock valued at $681,609,000 after purchasing an additional 792,304 shares in the last quarter. Finally, Norges Bank acquired a new stake in shares of Agilent Technologies in the second quarter valued at about $395,088,000.

Insider Buying and Selling

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 911 shares of the stock in a transaction on Tuesday, November 18th. The stock was sold at an average price of $143.24, for a total transaction of $130,491.64. Following the transaction, the chief executive officer owned 32,058 shares of the company’s stock, valued at $4,591,987.92. This represents a 2.76% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, VP Rodney Gonsalves sold 3,000 shares of the firm’s stock in a transaction on Wednesday, November 26th. The stock was sold at an average price of $154.99, for a total value of $464,970.00. Following the sale, the vice president owned 31,846 shares in the company, valued at $4,935,811.54. This trade represents a 8.61% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure.

Analyst Ratings Changes

A has been the topic of several recent analyst reports. The Goldman Sachs Group assumed coverage on shares of Agilent Technologies in a research report on Tuesday, December 9th. They set a “buy” rating and a $170.00 target price on the stock. Bank of America boosted their price target on Agilent Technologies from $150.00 to $165.00 and gave the stock a “neutral” rating in a research note on Tuesday, November 25th. UBS Group upped their price target on Agilent Technologies from $170.00 to $180.00 and gave the stock a “buy” rating in a report on Tuesday, November 25th. HSBC began coverage on Agilent Technologies in a research note on Tuesday, January 20th. They issued a “buy” rating and a $180.00 price objective for the company. Finally, Robert W. Baird boosted their target price on Agilent Technologies from $142.00 to $165.00 and gave the stock an “outperform” rating in a research report on Tuesday, November 25th. Two equities research analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $164.50.

Agilent Technologies Stock Performance

NYSE A opened at $128.87 on Wednesday. The company has a quick ratio of 1.52, a current ratio of 1.96 and a debt-to-equity ratio of 0.45. Agilent Technologies, Inc. has a fifty-two week low of $96.43 and a fifty-two week high of $160.27. The business has a fifty day moving average of $139.11 and a 200-day moving average of $135.37. The stock has a market cap of $36.45 billion, a price-to-earnings ratio of 28.20, a price-to-earnings-growth ratio of 3.70 and a beta of 1.30.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Monday, November 24th. The medical research company reported $1.59 EPS for the quarter, topping analysts’ consensus estimates of $1.58 by $0.01. Agilent Technologies had a return on equity of 25.20% and a net margin of 18.75%.The firm had revenue of $1.86 billion during the quarter, compared to analysts’ expectations of $1.83 billion. During the same quarter last year, the business posted $1.46 EPS. The firm’s quarterly revenue was up 9.4% compared to the same quarter last year. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. As a group, analysts predict that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, January 28th. Investors of record on Tuesday, January 6th were paid a dividend of $0.255 per share. The ex-dividend date of this dividend was Tuesday, January 6th. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.25. This represents a $1.02 annualized dividend and a dividend yield of 0.8%. Agilent Technologies’s payout ratio is currently 22.32%.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.